Industry News
Australian biotechs must merge or perish: Ernst and Young
Australia's biotechnology companies will have to merge or perish, according to leading industry analyst Ernst and Young. [ + ]
Xenome chief flags industry insurance fears
There are fears the current insurance industry upheaval will force some biotechs to the wall unless the Gene Technology Act 2000 is overhauled. [ + ]
Sequenom locates Asia HQ in Queensland
US-based genetics company, Sequenom, has chosen Queensland as the location for its Asia-Pacific regional headquarters, Premier Peter Beattie has announced.
[ + ]Mixed signals on stem cells creates concern
Australian stem cell researchers were confused by media reports today that the Federal government had banned human embryonic stem cell research. [ + ]
CSIRO lifting its game: Garrett
CSIRO was well on its way to addressing the raft of serious problems outlined in a confidential internal report, the organisation's chief has claimed. [ + ]
Cone snail proving to be companies' best friend
The cone snail, a marine snail from the Great Barrier Reef, is proving to be a vaulable ally in pain management drug research. [ + ]
MicroMedical's human heart trials imminent
Australia's first artificial hearts are to be implanted in human patients within weeks, according to the developer. [ + ]
Consolidation contributes to Agenix half-year profit
Agenix Limited (ASX: AGH) has announced a 435 per cent increase in after-tax profit to $1.7 million for the six months to December 31, 2001. [ + ]
Applications urged for $100m fund
Queensland researchers are being urged to take advantage of the state government's $100 million Smart State Research Facility Fund by getting their applications in before March 4.
[ + ]Autogen files new US patents
Australian genomics company Autogen has filed US patent applications for five new genes related to obesity and type 2 diabetes. [ + ]
New imaging company hits the capital-raising trail
Australia's latest biotech public share offering opened today as vision sciences company IATIA began efforts to raise $5 million. [ + ]
New IMB research targets cystic fybrosis
Queensland bioresearchers have discovered a promising method for treating a common bacterial infection afflicting cystic fibrosis patients. [ + ]
Go west, young biotech entrepreneur
BioWest, the first directory for the biotechnology industry in western Sydney, is being launched today by Kim Yeadon, NSW Minister for Western Sydney. [ + ]
No GM wheat here: Monsanto
The Australian branch of agricultural biotechnology giant Monsanto today refuted reports that its herbicide resistant genetically modified wheat seed was taking longer than expected to gain approval in the US. [ + ]
Heavyweight board a coup for start-up Farmacule
Queensland molecular farming start-up Farmacule Bioindustries has scored a mini-coup by appointing ex-Dow Chemical heavyweight Dr Paul Zorner to its board. [ + ]
